Showing results (81-90 of 94) with videos related to
Sort By:
Pageof 10
Nature Communications|January 29, 2022
Host receptor-targeted therapeutic approach to counter pathogenic New World mammarenavirus infectionsBrady T Hickerson, Tracy R Daniels-Wells, Cristian Payes, et al.The American Journal of Tropical Medicine and Hygiene|September 19, 2022
Estimation of the Minimal Rift Valley Fever Virus Protective Neutralizing Antibody Titer in Human Volunteers Immunized with MP-12 Vaccine Based on Protection in a Mouse Model of DiseaseDouglas M Watts, Jonna L B Westover, Pedro M Palermo, et al.Journal of Virology|March 20, 2024
Restoration of virulence in the attenuated Candid#1 vaccine virus requires reversion at both positions 168 and 427 in the envelope glycoprotein GPCJack H Nunberg, Jonna B Westover, Joanne York, et al.ACS Medicinal Chemistry Letters|April 20, 2023
An Isomer of Galidesivir That Potently Inhibits Influenza Viruses and Members of the Bunyavirales OrderKevin J Sparrow, Rinu Shrestha, James M Wood, et al.Virology|September 3, 2017
Heartland virus infection in hamsters deficient in type I interferon signaling: Protracted disease course ameliorated by favipiravirJonna B Westover, Johanna D Rigas, Arnaud J Van Wettere, et al.Nature Communications|September 13, 2023
Multifunctional human monoclonal antibody combination mediates protection against Rift Valley fever virus at low dosesNathaniel S Chapman, Ruben J G Hulswit, Jonna L B Westover, et al.Research Square|April 10, 2026
A Transgenic Syrian Hamster Model for New World Hemorrhagic Fever Mammarenavirus InfectionSamantha R Wasson, Yanan Liu, Minghao Li, et al.Plos Pathogens|February 17, 2026
Structural basis for recognition of Rift Valley fever virus Gn protein by a human neutralizing monoclonal antibody with a kappa light chainGuido C Paesen, Nathaniel S Chapman, Jonna B Westover, et al.Proceedings of the National Academy of Sciences of the United States of America|March 30, 2021
Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibitionNathaniel S Chapman, Haiyan Zhao, Nurgun Kose, et al.Antiviral Research|July 26, 2023
Meeting report: 36th International Conference on Antiviral Research in Lyon, France - March 13-17, 2023Jessica R Spengler, Kara Carter, Leen Delang, et al.Pageof 10